Long-term trends of the incidence of hepatocellular carcinoma in the Nagasaki prefecture, Japan

Oncology Reports

Volumn 21, Issue 1, 2009, Pages 223-227

  Taura, Naota ^a   Yatsuhashi, Hiroshi ^a   Nakao, Kazuhiko ^b   Ichikawa, Tatsuki ^b   Ishibashi, Hiromi ^a  

^a NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Aging; Hepatitis C virus; Hepatocellular carcinoma; Japan

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; JAPAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX RATIO; AGE DISTRIBUTION; CLINICAL TRIAL; INCIDENCE; LIVER TUMOR; MIDDLE AGED; MULTICENTER STUDY; VIROLOGY;

AGE DISTRIBUTION; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS B; HEPATITIS C; HUMANS; INCIDENCE; JAPAN; LIVER NEOPLASMS; MALE; MIDDLE AGED; SEX DISTRIBUTION;

EID: 61449302779     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000212     Document Type: Article

References (32)

1. El-Serag HB and Mason AC: Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med 160: 3227-3230, 2000.
2. El-Serag HB: Epidemiology of hepatocellular carcinoma. Clin Liver Dis 5: 87-107, 2001.
3. El-Serag HB, Hampel H, Yeh C and Rabeneck L: Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology 36: 1439-1445, 2002.
4. El-Serag HB: Hepatocellular carcinoma and hepatitis C in the United States. Hepatology 36: S74-S83, 2002.
5. El-Serag HB: Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol 35: S72-S78, 2002.
6. Hassan MM, Frome A, Patt YZ and El-Serag HB: Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States. J Clin Gastroenterol 35: 266-269, 2002.
7. El-Serag HB and Rudolph KL: Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-2576, 2007.
8. Kiyosawa K and Tanaka E: Characteristics of hepatocellular carcinoma in Japan. Oncology 62: 5-7, 2002.
9. McGlynn KA, Tsao L, Hsing AW, Devesa SS and Fraumeni JF Jr: International trends and patterns of primary liver cancer. Int J Cancer 94: 290-296, 2001.
10. Bosch FX, Ribes J, Diaz M and Cleries R: Primary liver cancer: worldwide incidence and trends. Gastroenterology 127: S5-S16, 2004.
11. Hamasaki K, Nakata K, Tsutsumi T, et al: Changes in the prevalence of hepatitis B and C infection in patients with hepatocellular carcinoma in the Nagasaki Prefecture, Japan. J Med Virol 40: 146-149, 1993.
12. Kato Y, Nakata K, Omagari K, et al: Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Analysis of infectious hepatitis viruses. Cancer 74: 2234-2238, 1994.
13. Shiratori Y, Shiina S, Imamura M, et al: Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan. Hepatology 22: 1027-1033, 1995.
14. Shiratori Y, Shiina S, Zhang PY, et al: Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan? Cancer 80: 2060-2067, 1997.
15. Kiyosawa K, Umemura T, Ichijo T, et al: Hepatocellular carcinoma: recent trends in Japan. Gastroenterology 127: S17-S26, 2004.
16. Yoshizawa H: Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the foreseeable future. Oncology 62: 8-17, 2002.
17. Umemura T and Kiyosawa K: Epidemiology of hepatocellular carcinoma in Japan. Hepatol Res 37 (Suppl 2): S95-S100, 2007.
18. Taura N, Yatsuhashi H, Hamasaki K, et al: Increasing hepatitis C virus-associated hepatocellular carcinoma mortality and aging: Long term trends in Japan. Hepatol Res 34: 130-134, 2006.
19. Taura N, Hamasaki K, Nakao K, et al: Aging of patients with hepatitis C virus-associated hepatocellular carcinoma: long-term trends in Japan. Oncol Rep 16: 837-843, 2006.
20. Nishiguchi S, Kuroki T, Nakatani S, et al: Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 346: 1051-1055, 1995.
21. Nishiguchi S, Shiomi S, Nakatani S, et al: Prevention of hepatocellular carcinoma in patients with chronic active hepatitis C and cirrhosis. Lancet 357: 196-197, 2001.
22. Kasahara A, Hayashi N, Mochizuki K, et al: Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group. Hepatology 27: 1394-1402, 1998.
23. Ikeda K, Saitoh S, Arase Y, et al: Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis. Hepatology 29: 1124-1130, 1999.
24. Makiyama A, Itoh Y, Kasahara A, et al: Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy. Cancer 101: 1616-1622, 2004.
25. Kato J, Miyanishi K, Kobune M, et al: Long-term phlebotomy with low-iron diet therapy lowers risk of development of hepatocellular carcinoma from chronic hepatitis C. J Gastroenterol 42: 830-836, 2007.
26. Furutani T, Hino K, Okuda M, et al: Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein. Gastroenterology 130: 2087-2098, 2006.
27. Muto Y, Sato S, Watanabe A, et al: Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol 3: 705-713, 2005.
28. Deuffic S, Poynard T and Valleron AJ: Correlation between hepatitis C virus prevalence and hepatocellular carcinoma mortality in Europe. J Viral Hepat 6: 411-413, 1999.
29. El-Serag HB and Mason AC: Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340: 745-750, 1999.
30. Planas R, Balleste B, Antonio Alvarez M, et al: Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patients. J Hepatol 40: 823-830, 2004.
31. Davila JA, Morgan RO, Shaib Y, McGlynn KA and El-Serag HB: Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology 127: 1372-1380, 2004.
32. Sasaki F, Tanaka J, Moriya T, et al: Very low incidence rates of community-acquired hepatitis C virus infection in company employees, long-term inpatients, and blood donors in Japan. J Epidemiol 6: 198-203, 1996.